Fed. Circ. Urged Not To Stay Immunity Ruling For Appeal

By Dani Kass (November 6, 2018, 5:38 PM EST) -- A trio of generic-drug makers have urged the Federal Circuit not to stay its ruling that sovereign immunity doesn't apply in inter partes reviews, arguing that Allergan PLC and the St. Regis Mohawk tribe haven't proven the U.S. Supreme Court would have a reason to take up their case or overturn the decision....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!